Abbott Labs Stock Leapfrogs A Key Line Despite A Wild Card Obscuring 2022

Abbott Labs Stock Leapfrogs A Key Line Despite A Wild Card Obscuring 2022
·3 min read

Abbott Laboratories squashed third-quarter estimates Wednesday, helped by $1.9 billion in sales of Covid tests. ABT stock rose in response.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting